NeuroBo Pharmaceuticals, Inc. Gains 95.19%
Wed, Feb 12, 2020 at 05:30 PM
NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) shot up at $30, representing a gain of 95.2%. On Tue 11 Feb 20, NRBO:NASDAQ touched a New 2-Week High of $15.37. From Wed 22 Jan 20, the stock recorded 64.29% Up Days and 73.33% Green Days
Top 10 Gainers:
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 95.19%
- Canaan Inc. (CAN:NASDAQ), 82.73%
- Noble Corporation plc (NE:NYSE), 30%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 27.19%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 25.94%
- Valeritas Holdings, Inc. (VLRX:NASDAQ), 24.73%
- Natural Health Trends Corp. (NHTC:NASDAQ), 24.17%
- KBS Fashion Group Limited (KBSF:NASDAQ), 20.62%